1. Home
  2. FSBW vs ENGN Comparison

FSBW vs ENGN Comparison

Compare FSBW & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

N/A

Current Price

$42.85

Market Cap

305.6M

Sector

Finance

ML Signal

N/A

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$8.39

Market Cap

379.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBW
ENGN
Founded
1936
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
305.6M
379.3M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
FSBW
ENGN
Price
$42.85
$8.39
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$44.00
$22.71
AVG Volume (30 Days)
14.6K
528.5K
Earning Date
01-20-2026
12-19-2025
Dividend Yield
2.61%
N/A
EPS Growth
N/A
N/A
EPS
4.09
N/A
Revenue
$140,954,000.00
N/A
Revenue This Year
$10.46
N/A
Revenue Next Year
$4.42
N/A
P/E Ratio
$10.50
N/A
Revenue Growth
1.07
N/A
52 Week Low
$34.61
$2.65
52 Week High
$46.20
$11.14

Technical Indicators

Market Signals
Indicator
FSBW
ENGN
Relative Strength Index (RSI) 68.46 55.12
Support Level $39.48 $7.77
Resistance Level $43.24 $8.49
Average True Range (ATR) 0.69 0.61
MACD 0.28 0.07
Stochastic Oscillator 94.68 66.45

Price Performance

Historical Comparison
FSBW
ENGN

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: